These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21803105)

  • 1. Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA.
    Hara H; Mouri A; Yonemitsu Y; Nabeshima T; Tabira T
    Vaccine; 2011 Oct; 29(43):7474-82. PubMed ID: 21803105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
    Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
    FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
    Hara H; Inoue M; Adachi K; Yonemitsu Y; Hasegawa M; Nabeshima T; Tabira T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
    Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
    Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
    Matsuda J; Kaminaka K; Nozaki C
    Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice.
    Li Y; Ma Y; Zong LX; Xing XN; Guo R; Jiang TZ; Sha S; Liu L; Cao YP
    J Neuroimmunol; 2012 Aug; 249(1-2):16-26. PubMed ID: 22626444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
    J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
    Kim HD; Maxwell JA; Kong FK; Tang DC; Fukuchi K
    Biochem Biophys Res Commun; 2005 Oct; 336(1):84-92. PubMed ID: 16126169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer vaccine].
    Tabira T
    Nihon Rinsho; 2008 Oct; 66(10):2008-12. PubMed ID: 18939505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease.
    Wang YJ; Gao CY; Yang M; Liu XH; Sun Y; Pollard A; Dong XY; Wu XB; Zhong JH; Zhou HD; Zhou XF
    Brain Behav Immun; 2010 Nov; 24(8):1281-93. PubMed ID: 20595065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trend of immunotherapy for Alzheimer's disease].
    Matsumoto SE; Tabira T
    Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.